Maria Stangou Selected Research

Sepsis (Septicemia)

1/2005

Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Stangou Research Topics

Disease

11	IGA Glomerulonephritis (IGA Nephropathy) 05/2021 - 07/2004
7	Proteinuria 01/2022 - 01/2005
5	Glomerulonephritis 01/2021 - 02/2010
4	Fibrosis (Cirrhosis) 01/2020 - 01/2005
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 07/2017
3	Atrophy 01/2020 - 01/2008
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2017 - 01/2008
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 02/2021
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 07/2017
2	Segmental glomerulosclerosis 01/2020 - 01/2019
2	Membranous Glomerulonephritis (Membranous Nephropathy) 06/2019 - 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2022
1	Chronic Progressive Multiple Sclerosis 01/2022
1	Arteriovenous Fistula 10/2021
1	Vascular Calcification 10/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Anemia 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Sclerosis 07/2017
1	Hypertension (High Blood Pressure) 11/2011
1	Disease Progression 11/2011
1	Nephritis 01/2011
1	Hypovolemia 01/2011
1	Body Weight (Weight, Body) 01/2011
1	Anuria 01/2008
1	Inflammation (Inflammations) 01/2008
1	Barakat syndrome 04/2005
1	Hypoparathyroidism 04/2005
1	Deafness (Deaf Mutism) 04/2005
1	Sepsis (Septicemia) 01/2005
1	Rapidly progressive glomerulonephritis with pulmonary hemorrhage 01/2005
1	Vasculitis (Vasculitides) 01/2005
1	Calcinosis 10/2002
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 06/2002

Drug/Important Bio-Agent (IBA)

4	CreatinineIBA 01/2022 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2016
3	SteroidsIBA 01/2022 - 06/2011
3	Immunoglobulin A (IgA)IBA 05/2021 - 02/2010
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2005
3	Azathioprine (Imuran)FDA LinkGeneric 02/2018 - 06/2011
3	CytokinesIBA 07/2017 - 09/2009
2	galactosyl-deficient IgA1IBA 05/2021 - 03/2016
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2019
2	AutoantibodiesIBA 06/2019 - 02/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2018 - 01/2005
2	Interleukin-2 (IL2)IBA 07/2017 - 09/2013
1	Serum AlbuminIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Immunoglobulin D (IgD)IBA 01/2022
1	ocrelizumabIBA 01/2022
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 05/2021
1	Complement Factor B (Factor B)IBA 01/2021
1	3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 01/2020
1	ParaffinIBA 01/2020
1	IronIBA 01/2020
1	sucroferric oxyhydroxideIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	AntibodiesIBA 06/2019
1	Phospholipase A2 ReceptorsIBA 06/2019
1	Complement Inactivating AgentsIBA 01/2019
1	Calcineurin InhibitorsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Methylprednisolone FDA LinkGeneric 02/2018
1	Prednisolone (Predate)FDA LinkGeneric 02/2018
1	Interleukin-12 (IL 12)IBA 07/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2017
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 11/2011
1	AldosteroneIBA 11/2011
1	Proteins (Proteins, Gene)FDA Link 06/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2011
1	oprelvekin (Neumega)FDA Link 01/2011
1	Vasopressins (Vasopressin)IBA 01/2011
1	Fibronectins (Fibronectin)IBA 01/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2011
1	Interleukin-11 (Interleukin 11)IBA 01/2011
1	Myeloblastin (Proteinase 3)IBA 02/2010
1	Peroxidase (Myeloperoxidase)IBA 02/2010
1	Epidermal Growth Factor (EGF)IBA 09/2009
1	Interleukin-6 (Interleukin 6)IBA 09/2009
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2009
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 04/2005
1	DNA (Deoxyribonucleic Acid)IBA 04/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2005
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 07/2004
1	Pharmaceutical PreparationsIBA 06/2002

Therapy/Procedure

4	Renal Dialysis (Hemodialysis) 01/2022 - 10/2002
2	Therapeutics 01/2020 - 06/2002
1	Hemodiafiltration 01/2022
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 02/2021
1	Aftercare (After-Treatment) 01/2005
1	Plasma Exchange 06/2002